-
Precision Medicine for “All of Us”
Northwestern will play a key role in “All of Us,” a groundbreaking national research effort to gather data from one million or more people in order to advance precision medicine.
-
New Insights Into Protein’s Role in Inflammatory Response
A protein called POP2 inhibits a key inflammatory pathway, calming the body’s inflammatory response before it can become destructive, Northwestern Medicine scientists have found.
-
Reversing Fetal Alcohol Damage After Birth
Two commonly used drugs erased the learning and memory deficits caused by fetal alcohol exposure when the drugs were given after birth, according to a new study.
-
How Babies’ Environments Lead to Poor Health Later
Northwestern scientists have found that nutritional, microbial and psychosocial exposures early in infant development predict DNA methylation later in life.
-
New Technology to Manipulate Cells Could One Day Help Treat Parkinson’s, Arthritis, Other Diseases
A synthetic material developed at Northwestern Medicine could direct a patient’s existing cells to transform into stem cells, creating a new treatment path for stem cell therapy.
-
Novel Screening Method Reveals Glioblastoma Drug Target
Scientists used a new approach to identify a promising therapeutic target for glioblastoma, which was previously overlooked in traditional approaches.
-
Investigating Relevance of Internal Medicine Recertification Exam
Almost 70 percent of questions on the American Board of Internal Medicine’s Maintenance of Certification exam concurred with the frequency of conditions seen in general internal medicine practice, according to a JAMA study.
-
Investigating the Survival Benefit of Aggressive Procedure for Melanoma
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
-
Investigating the Financial Burden of Cancer Drugs on Medicare Patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare’s prescription drug benefit program, Part D, according to a new study.
-
Nanomedicine Opens Door to Precision Medicine for Brain Tumors
Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating glioblastoma.
-
Root of Cardiac Fibrosis Defined
Northwestern Medicine scientists identified a novel molecular mechanism that regulates scar formation in the heart, a symptom of aging and heart disease.
-
PhD Student Explores Enzyme’s Role in Aggressive Brain Tumor
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
-
Scientists Discover Novel Treatment Target for Pulmonary Fibrosis
Northwestern Medicine scientists have discovered that a unique population of immune cells play a key role in the development of pulmonary fibrosis, a fatal lung disease.
-
Lloyd-Jones Named AHA Physician of the Year
Donald Lloyd-Jones, MD, ScM, senior associate dean for clinical and translational research and chair of Preventive Medicine, has been named Physician of the Year by the American Heart Association.
-
Cosmetic Complaints Climb, But Products Still on Market
Consumer complaints for cosmetic products have more than doubled, but consumers may remain at risk because the industry receives little regulatory scrutiny, according to new research.
-
Sugar-Coated Nanomaterial Excels at Promoting Bone Growth
Scientists have designed a promising bioactive nanomaterial with the potential to stimulate bone regeneration and improve quality of life for surgical patients and lead to less-invasive procedures.
-
Transforming Medical Education as Translational Science
A recent seminar explored the topic of innovation in medical education and the role of mastery learning in training of the next generation of physicians.
-
Stem Cell Transplant May Not Benefit Double-Hit Lymphoma Patients
A new study finds that patients with double-hit lymphoma who received autologous stem cell transplantation saw no survival benefit, compared to patients who did not undergo the procedure.
-
Technology Unlocks Mold Genomes for New Drugs
Northwestern Medicine scientists have developed technology that uses genomics and data analytics to efficiently screen for molecules produced by molds to find new drug prospects.
-
Topping-Off Ceremony Marks Milestone for Simpson Querrey Biomedical Research Center
The Northwestern community gathered to celebrate as a ceremonial steel beam was set in place atop the Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center.
